A citation-based method for searching scientific literature

Csaba Bödör, Donát Alpár, Dóra Marosvári, Bence Galik, Hajnalka Rajnai, Bence Bátai, Ákos Nagy, Béla Kajtár, Adrienn Burján, Beáta Deák, Tamás Schneider, Hussain Alizadeh, András Matolcsy, Sebastian Brandner, James Storhoff, Ning Chen, Mingdong Liu, Nadeem Ghali, Irén Csala, Attila G Bagó, Attila Gyenesei, Lilla Reiniger. J Neuropathol Exp Neurol 2020
Times Cited: 15







List of co-cited articles
131 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
60

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen McPhail, Yan W Asmann, Jan Egan, Jackline Ayres da Silva, David Schiff, M Beatriz Lopes, Paul A Decker,[...]. Clin Cancer Res 2015
125
53

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
53

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
46

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah S Tang, Carl Campos, Derrek Schartz, Paolo Codega, Donna Nichol, Owen Clark, Wan-Ying Hsieh,[...]. Cancer Discov 2017
207
46

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, Brigitte C Widemann, John A Butman, Roland Schmitz, Yandan Yang, Diane E Cole, Christopher Melani, Christine S Higham,[...]. Cancer Cell 2017
288
40


MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.
Naema Nayyar, Michael D White, Corey M Gill, Matthew Lastrapes, Mia Bertalan, Alexander Kaplan, Megan R D'Andrea, Ivanna Bihun, Andrew Kaneb, Jorg Dietrich,[...]. Blood Adv 2019
43
40

The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
I Vater, M Montesinos-Rongen, M Schlesner, A Haake, F Purschke, R Sprute, N Mettenmeyer, I Nazzal, I Nagel, J Gutwein,[...]. Leukemia 2015
99
40

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.
Sophie Camilleri-Broët, Emmanuelle Crinière, Philippe Broët, Vincent Delwail, Karima Mokhtari, Anne Moreau, Michèle Kujas, Martine Raphaël, Wafae Iraqi, Catherine Sautès-Fridman,[...]. Blood 2006
259
40

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
270
33

Mutational analysis of primary central nervous system lymphoma.
Aurélie Bruno, Blandine Boisselier, Karim Labreche, Yannick Marie, Marc Polivka, Anne Jouvet, Clovis Adam, Dominique Figarella-Branger, Catherine Miquel, Sandrine Eimer,[...]. Oncotarget 2014
115
33

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
David W Scott, George W Wright, P Mickey Williams, Chih-Jian Lih, William Walsh, Elaine S Jaffe, Andreas Rosenwald, Elias Campo, Wing C Chan, Joseph M Connors,[...]. Blood 2014
395
33

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
T Nakamura, K Tateishi, T Niwa, Y Matsushita, K Tamura, M Kinoshita, K Tanaka, S Fukushima, H Takami, H Arita,[...]. Neuropathol Appl Neurobiol 2016
112
33

Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
M Montesinos-Rongen, A Brunn, S Bentink, K Basso, W K Lim, W Klapper, C Schaller, G Reifenberger, J Rubenstein, O D Wiestler,[...]. Leukemia 2008
111
33


Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova,[...]. Blood 2016
305
33

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
33

Primary CNS lymphoma commonly expresses immune response biomarkers.
Alexander Ou, Ashley Sumrall, Surasak Phuphanich, David Spetzler, Zoran Gatalica, Joanne Xiu, Sharon Michelhaugh, Andrew Brenner, Manjari Pandey, Santosh Kesari,[...]. Neurooncol Adv 2020
17
26

Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.
Alberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, Naïma Habbita, Marta Rossetto, Alice Laurenge, Aurélie Bruno, Anne Jouvet, Marc Polivka, Clovis Adam,[...]. Clin Cancer Res 2012
162
26

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
W Kraan, H M Horlings, M van Keimpema, E J M Schilder-Tol, M E C M Oud, C Scheepstra, P M Kluin, M J Kersten, M Spaargaren, S T Pals. Blood Cancer J 2013
134
26

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.
Lakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, Srinivasan Mukundan, Margaretha G M Roemer, Bjoern Chapuy, Philippe Armand, Scott J Rodig, Margaret A Shipp. Blood 2017
251
26

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
713
26

Oncogenically active MYD88 mutations in human lymphoma.
Vu N Ngo, Ryan M Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, Weihong Xu, Yandan Yang, Hong Zhao,[...]. Nature 2011
26

Genomic characterization of primary central nervous system lymphoma.
Kazutaka Fukumura, Masahito Kawazu, Shinya Kojima, Toshihide Ueno, Eirin Sai, Manabu Soda, Hiroki Ueda, Takahiko Yasuda, Hiroyuki Yamaguchi, Jeunghun Lee,[...]. Acta Neuropathol 2016
95
26


Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.
H Schwindt, I Vater, M Kreuz, M Montesinos-Rongen, A Brunn, J Richter, S Gesk, O Ammerpohl, O D Wiestler, D Hasenclever,[...]. Leukemia 2009
49
20

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
J L Villano, M Koshy, H Shaikh, T A Dolecek, B J McCarthy. Br J Cancer 2011
296
20

Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Laura S Hiemcke-Jiwa, Ninette H Ten Dam-van Loon, Roos J Leguit, Stefan Nierkens, Jeannette Ossewaarde-van Norel, Joke H de Boer, Floor F Roholl, Roel A de Weger, Manon M H Huibers, Jolanda D F de Groot-Mijnes,[...]. JAMA Ophthalmol 2018
47
20

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Manuel Montesinos-Rongen, Dirk Van Roost, Carlo Schaller, Otmar D Wiestler, Martina Deckert. Blood 2004
116
20

Whole exome sequencing identifies mutational signatures of vitreoretinal lymphoma.
Junwon Lee, Borahm Kim, Hyeonah Lee, Heejung Park, Suk Ho Byeon, Jong Rak Choi, Sung Chul Lee, Seung-Tae Lee, Christopher Seungkyu Lee. Haematologica 2020
11
27

High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
Irina Bonzheim, Sabrina Giese, Christoph Deuter, Daniela Süsskind, Manfred Zierhut, Maria Waizel, Peter Szurman, Birgit Federmann, Janine Schmidt, Leticia Quintanilla-Martinez,[...]. Blood 2015
114
20

CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Ichiro Yonese, Hiroshi Takase, Mayumi Yoshimori, Erika Onozawa, Akiho Tsuzura, Tohru Miki, Manabu Mochizuki, Osamu Miura, Ayako Arai. Eur J Haematol 2019
36
20

Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Andi K Cani, Daniel H Hovelson, Hakan Demirci, Mark W Johnson, Scott A Tomlins, Rajesh C Rao. Oncotarget 2017
53
20

TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Leandro Venturutti, Matt Teater, Andrew Zhai, Amy Chadburn, Leena Babiker, Daleum Kim, Wendy Béguelin, Tak C Lee, Youngjun Kim, Christopher R Chin,[...]. Cell 2020
30
20

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
20

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Stuart E Lacy, Sharon L Barrans, Philip A Beer, Daniel Painter, Alexandra G Smith, Eve Roman, Susanna L Cooke, Camilo Ruiz, Paul Glover, Suzan J L Van Hoppe,[...]. Blood 2020
129
20

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.
Han W Tun, Patrick B Johnston, Lisa M DeAngelis, Pamela J Atherton, Levi D Pederson, Patricia A Koenig, Craig B Reeder, Antonio M Padula Omuro, David Schiff, Brian O'Neill,[...]. Blood 2018
52
20

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Jacoline E C Bromberg, Samar Issa, Katerina Bakunina, Monique C Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Harry C Schouten, Wendy B C Stevens, Josee M Zijlstra,[...]. Lancet Oncol 2019
95
20

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma.
John G Gribben, Nathan Fowler, Franck Morschhauser. J Clin Oncol 2015
182
20

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Valter Torri, Christopher P Fox, Paul La Rosée, Elisabeth Schorb,[...]. Lancet Haematol 2016
295
20

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Matthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, Mark Leick, Bryan D Choi, Zachariah DeFilipp, Yi-Bin Chen, Jeremy Abramson, Jennifer Crombie, Philippe Armand,[...]. Blood 2019
119
20

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
George Wright, Bruce Tan, Andreas Rosenwald, Elaine H Hurt, Adrian Wiestner, Louis M Staudt. Proc Natl Acad Sci U S A 2003
730
20

Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.
Yangying Zhou, Wei Liu, Zhijie Xu, Hong Zhu, Desheng Xiao, Weiping Su, Ruolan Zeng, Yuhua Feng, Yumei Duan, Jianhua Zhou,[...]. Neoplasia 2018
23
20

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.
James L Rubenstein, Huimin Geng, Eleanor J Fraser, Paul Formaker, Lingjing Chen, Jigyasa Sharma, Phoebe Killea, Kaylee Choi, Jenny Ventura, John Kurhanewicz,[...]. Blood Adv 2018
83
20

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.
Yasuo Takashima, Yasushi Sasaki, Azusa Hayano, Jumpei Homma, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Shin Ishizawa, Hiroaki Hondoh, Takashi Tokino,[...]. Oncotarget 2018
18
20

Primary CNS Lymphoma.
Christian Grommes, Lisa M DeAngelis. J Clin Oncol 2017
243
20

Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Melissa Alame, Marion Pirel, Valérie Costes-Martineau, Luc Bauchet, Michel Fabbro, Alicia Tourneret, Laura De Oliveira, Luc Durand, Pascal Roger, Samia Gonzalez,[...]. Virchows Arch 2020
16
13

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Bjoern Chapuy, Hongwei Cheng, Akira Watahiki, Matthew D Ducar, Yuxiang Tan, Linfeng Chen, Margaretha G M Roemer, Jing Ouyang, Amanda L Christie, Liye Zhang,[...]. Blood 2016
50
13

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
Olivier Gasser, Florian K Bihl, Marcel Wolbers, Elisabetta Loggi, Ingrid Steffen, Hans H Hirsch, Huldrych F Günthard, Bruce D Walker, Christian Brander, Manuel Battegay,[...]. PLoS Med 2007
63
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.